New drug aims to shrink heart plaque after attack
NCT ID NCT07301034
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a new medicine called ziltivekimab can reduce fatty plaque buildup in heart arteries after a heart attack. About 332 participants will receive either the drug or a placebo for 15 months. The goal is to see if the drug helps control artery disease and prevent future heart problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
AOU Maggiore della Carità di Novara - Dipartimento Toraco-Cardio-Vascolare - SCDU Cardiologia
NOT_YET_RECRUITINGNovara, 28100, Italy
-
Aalborg Universitetshospital Hjertemedicinsk Afdeling
NOT_YET_RECRUITINGGistrup, 9260, Denmark
-
Azienda Ospedaliera San Giovanni Addolorata
NOT_YET_RECRUITINGRome, Lazio, 00184, Italy
-
Azienda Ospedaliera Universitaria San Luigi Gonzaga - S.C.D.O. Microcitemie e malattie rare ematologiche
NOT_YET_RECRUITINGOrbassano, 10043, Italy
-
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII
NOT_YET_RECRUITINGBergamo, Lombardy, 24127, Italy
-
DAI Scienze Mediche - UOC Endocrinologia
NOT_YET_RECRUITINGMessina, Sicily, 98124, Italy
-
Erasmus MC
NOT_YET_RECRUITINGRotterdam, 3015 GD, Netherlands
-
Fondazione Policlinico Universitario Agostino Gemelli IRCS
NOT_YET_RECRUITINGRome, 00168, Italy
-
HUG-Service de Cardiologie
NOT_YET_RECRUITINGGeneva, 1205, Switzerland
-
Hospital Universitario Marqués de Valdecilla
NOT_YET_RECRUITINGSantander, 39008, Spain
-
Hospital Universitario de la Princesa
NOT_YET_RECRUITINGMadrid, 28006, Spain
-
IRCCS Policlinico San Donato
NOT_YET_RECRUITINGSan Donato Milanese, 20097, Italy
-
Inselspital-Universitätsklinik für Kardiologie
RECRUITINGBern, 3010, Switzerland
-
LUKS-Herzzentrum
RECRUITINGLucerne, 6000, Switzerland
-
Medizinische Universität Wien
NOT_YET_RECRUITINGVienna, 1090, Austria
-
Ospedale Policlinico San Martino
NOT_YET_RECRUITINGGenova, 16132, Italy
-
Presidio Ospedaliero di Rivoli
NOT_YET_RECRUITINGRivoli, To, 10098, Italy
-
Radboudumc
NOT_YET_RECRUITINGNijmegen, 6525 GA, Netherlands
-
Rigshospitalet - Kardiologisk Forskningsenhed
NOT_YET_RECRUITINGKøbenhavn Ø, 2100, Denmark
-
Universitäres Herzzentrum
RECRUITINGBasel, 4031, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which strategy wins for heart attack patients with multiple blocked arteries?
- Can immune cells predict how well the heart heals after an attack?
- Could a hot bath after exercise help heal the heart?
- Can a Plant-Based diet calm the immune system after a heart attack?
- Could a personal trainer cut heart attack deaths?
- Drinking water may shield kidneys during emergency heart procedures